HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Additionally, one-way ANCOVA revealed a significant difference between the groups post-treatment (F(1,31) = 6.011, P = 0.020, η2 = 0.162) and one month post-treatment (F(1,31) = 4.889, P = 0.035, η2 = 0.136), with ML SI being significantly lower in the exergaming group than the balance training group at both time points. In both group, the DPSI also decreased significantly one month post-treatment compared to before and after treatment (P = 0.040 and P = 0.018, respectively). …”

Decreased proliferation in <i>AnxA2</i>kd and <i>AnxA5</i>kd cells. by Damian C. Genetos (325684)

Fig 5 - by Varun Tiwari (9258130)

Number of alveoli based on data from Tschanz et al. [6] together with our linearly scaled data (our data multiplied by 5.04). by David Haberthür (8407422)

The effect of instilling the ophthalmic solution on the LF/HF ratio and typical cases of fluctuations in the LF/HF ratio over time in the DE and non-DE groups. by Minako Kaido (309626)

Subjects:

5-hmC is increased during THP1 macrophage differentiation. by Fangfang Sun (2410654)

mAP0.5 Curves of various models. by Yaojun Zhang (389482)

(R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

“…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”

Decrease of GFP-TbAtg8 fluorescence during starvation. by Remo S. Schmidt (546946)

UVB irradiation decreased TM expression in HaCaT cells. by Huey-Chun Huang (429098)

“…The untreated cells at each time point served as a control for each time point. The results are presented as the mean ± standard deviation from three independent experiments. …”

Blocking C5L2 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). by Jian Hao (160736)

Telmisartan decreased NO production in LPS-stimulated BV2 and primary neonatal rat glial cells. by Nofar Torika (3169497)

Sudachitin decreases osteoclastogenesis induced by RANKL in cultures of osteoclast precursors. by Yoko Ohyama (4775400)

Decreased natTregs observed in the lungs in the absence of TLR2. by Amanda McBride (421742)

Decreased cell viability and ROS production induced by oxidative treatment. by Sandra M. Martín-Guerrero (780940)

Poly (I:C) decreases HIV-1 replication in PBMCs. by Christiane Rollenhage (762318)

Correlates of osteogenic differentiation. by Fabian Westhauser (5314436)

Overexpression of Pax6 decreases Olig2 protein levels. by Eun Sook Jang (217069)

“…(<b>a</b>) Oli-Neu cells were transfected with flag-tagged WT Pax6 (WT), Pax6(5a)R128C (128), or eGFP control vector (-). (<b>b</b>) Immunostaining analysis 72 hrs after transfection shows that overexpressed Pax6 decreases Olig2 levels in Oli-Neu cells. …”

Eligibility criteria for expert judges (≥5 points). by Thiago Serrão-Pinto (17817523)